Exploratory quantities subjected to post hoc analysis
| Quantity | Time of measure (months) | Type of quantity |
|---|---|---|
| Demographic | ||
| Sex | BL | Binary (M/F) |
| Age, height, weight | BL, 1, 4, 12 | Continuous |
| Marital, occupational, educational status | BL | Categorical |
| Clinical | ||
| NYHA classification | BL, 1, 4, 12 | Continuous |
| Previous heart disease, diabetes mellitus, kidney disease, pulmonary disease (COPD), comorbidities, hypertension, dyslipidaemia, smoking | BL | Binary (Y/N) |
| Medication | BL, 1, 4, 12 | Binary (Y/N) |
| AF specific data | ||
| Type of atrial fibrillation | BL | Categorical |
| Number of ablations | BL, 1, 4, 12 | Binary (Y/N) |
| Atrial fibrillation symptoms | BL, 1, 4, 12 | Continuous |
| CHA2DS2VASc score | BL, 1, 4, 12 | Continuous |
| The European Heart Rhythm Association symptom score | BL, 1, 4, 12 | Continuous |
| Paraclinical and imaging | ||
| Blood work (Haemoglobin, potassium, sodium, creatine, pro-BNP, BNP and copeptin) | BL, 1, 4, 12 | Continuous |
| Electrocardiogram | BL, 4, 12 | Continuous |
| Physical function | ||
| 6 min walking test46 | BL, 1, 4, 12 | Continuous |
| Sit to stand test47 | 1, 4, 12 | Continuous |
| EVO recording | 1, 4, 12 | Categorical |
| Questionnaires | ||
| Physical activity level48 | BL, 1, 4, 6, 12, 24 | Binary (Y/N) |
| SF-3649 HADS,50 QoL-CV51 | BL, 1, 4, 6, 12, 24 | Continuous |
| Emotions and Health52 | BL | Continuous |
| Rehabilitation53 | 12 | Continuous |
| HeartQoL R,54 EQ-5D55 | BL, 6, 12, 24 | Continuous |
| IPAQ56 | 1, 4, 12, 24 | Continuous |
| PSQI58 | 1, 6 | Continuous |
| AFEQT59 | BL, 1, 4, 12, 24 | Continuous |
AFEQT, Atrial Fibrillation Effect on Quality-of-life; BL, baseline; CHA2DS2VASc, score for Atrial Fibrillation Stroke Risk; EQ-5D, EuroQoL; HADS, Hospital Anxiety and Depression Scale; HeartQoL R, Heart-Related Quality of Life; IPAQ, International Physical Activity Questionnaire; PSQI, Pittsburgh Sleep Quality Index; QoL-CV, Quality of Life—Cardiac Version; SF-36, Short Form 36.